WuXi AppTec (02359.HK): Wrongly Added to US DoD 1260H List, to Immediately Challenge and Correct

Newtimespace (newtimespace.com) reports that WuXi AppTec (2359.HK) announced the U.S. Department of Defense erroneously included the Company in the updated Section 1260H "Chinese military companies" list on June 8, 2026 (U.S. time); the Company believes the designation is clearly erroneous and will immediately challenge and correct it, emphasizing it does not meet the statutory criteria as it is not owned, controlled, or affiliated with any Chinese military or government entity, has not provided services to the Chinese military, and has no association with the Chinese defense industrial base or military-civil fusion program, while noting its global compliance record including over 50 regulatory inspections and hundreds of client audits passed in 2025, and advising shareholders and investors to exercise caution when trading its securities.

Newtimespace (newtimespace.com) reports that WuXi AppTec Co., Ltd. (2359.HK) issued a voluntary announcement. The Company noted that on June 8, 2026 (U.S. time), the U.S. Department of Defense erroneously included WuXi AppTec in the formal updated list of "Chinese military companies" designated under Section 1260H. The Company believes that the designation of WuXi AppTec in this updated list, and the purported basis for such designation, are clearly erroneous, and WuXi AppTec will immediately take measures to challenge and correct this erroneous designation.

WuXi AppTec does not meet the statutory criteria for being designated as a "Chinese military company." Given that (i) the Company is not owned, controlled, or affiliated with any military or government entity of the People's Republic of China; (ii) the Company has not provided services to the Chinese military; and (iii) the Company has no association with the Chinese defense industrial base or military-civil fusion program, the alleged basis for including the Company in the 1260H list is completely inconsistent with the facts.

WuXi AppTec is an independent publicly listed company that works with thousands of partners across more than 30 countries to develop life-saving medicines for patients worldwide. With a commitment to excellence, safety, and innovation, the Company has earned the trust of its clients for over 25 years. The Company's global operating track record fully demonstrates its reputation for integrity, having successfully passed over 50 inspections by U.S., EU, and other regulatory authorities, as well as hundreds of client audits in 2025 alone.

Shareholders and prospective investors are advised to exercise caution when dealing in the Company's securities.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.

×
Share to WeChat

Open WeChat, use the "Scan", and share to my Moments.